Treatment adherence in concurrent chemoradiation in patients with locally advanced non-small cell lung carcinoma: Results of daily intravenous prehydration-Reference-Cited by-同舟云学术

Treatment adherence in concurrent chemoradiation in patients with locally advanced non-small cell lung carcinoma: Results of daily intravenous prehydration

Published:2014-03 Issue:3 Volume:110 Page:488-492
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Uyterlinde Wilma,Chen Chun,Nijkamp Jasper^ORCID,Obbink Marieke Groot,Sonke Jan-Jakob,Belderbos Jose,van den Heuvel Michel

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference25 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J Clin Oncol,2010

2. Chemoradiation therapy in nonsmall cell lung cancer;Baas;Curr Opin Oncol,2011

3. State-of-the-art lung cancer radiation therapy;Belderbos;Expert Rev Anticancer Ther,2009

4. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy;Belderbos;Radiother Oncol,2003

5. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer;Schaake-Koning;N Engl J Med,1992

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect of food derived nutrients on cisplatin nephrotoxicity and its mechanism;Food & Function;2022

2. Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis;Interactive CardioVascular and Thoracic Surgery;2021-11-04

3. Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer;British Journal of Cancer;2020-12-01

4. Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients;Frontiers in Pharmacology;2020-06-26

5. Difference in decline in renal function due to cisplatin after a short or long hydration scheme in non–small‐cell lung cancer: A retrospective cohort study (HYCIS‐XL);Journal of Clinical Pharmacy and Therapeutics;2020-06-13